Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1,333.2% | -77.7% | 347.6% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 52.6% | -220.1% | -58.1% | -800.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -920.2% | -8,171% | -496.7% | -730% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,025.7% | -8,180.2% | -496.7% | -1,446.6% |
| EPS Diluted | -0.03 | -0.017 | -0.005 | -0.004 |
| % Growth | -74.1% | -214.8% | -42.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |